Cargando…
WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria
The recent World Health Organization moratorium on rectal artesunate (RAS) for pre-referral treatment of severe childhood malaria is costing young lives. The decision was based on disappointing findings from a large observational study that provided RAS to community health workers with little traini...
Autores principales: | Peto, Thomas J, Watson, James A, White, Nicholas J, Dondorp, Arjen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318884/ https://www.ncbi.nlm.nih.gov/pubmed/36722432 http://dx.doi.org/10.1093/trstmh/trad002 |
Ejemplares similares
-
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria
por: Watson, James A., et al.
Publicado: (2023) -
Pre‐referral rectal artesunate for severe malaria
por: Okebe, Joseph, et al.
Publicado: (2014) -
Stopping prereferral rectal artesunate — a grave error
por: Watson, James A, et al.
Publicado: (2022) -
Pre-referral rectal artesunate in severe malaria: flawed trial
por: Hirji, Karim F, et al.
Publicado: (2011) -
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial
por: Gomes, MF, et al.
Publicado: (2009)